Ledger.Open graph →
SEC Form D · filed January 16, 2025

Rivus Pharmaceuticals, Inc

Offering
$57.0M
Sold
$57.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Erin Lavelle · Redmond, WADirectorAllen Cunningham · Charlottesville, VAExec · DirectorTom O'Neil · Charlottesville, VAExecRick Winningham · Charlottesville, VADirectorRick Winningham · Charlottesville, VADirectorShaharyar Khan · Charlottesville, VAExec · DirectorTom O'Neil · Charlottesville, VAExecDerek Dirocco · South San Francisco, CADirectorRobert Schott · Charlottesville, VAExecFrancesco De Rubertis · ST HELIER, Y9DirectorRobert Schott · Charlottesville, VAExecJayson Dallas · Charlottesville, VAExec · DirectorShaharyar Khan · Charlottesville, VAExec · DirectorAllen Cunningham · Charlottesville, VAExec · DirectorErin Lavelle · Redmond, WADirectorJayson Dallas · Charlottesville, VAExec · DirectorIan Smith · New York, NYDirectorIan Smith · Windermere, FLDirectorFrancesco De Rubertis · BRIGHTON, MADirectorDerek Dirocco · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗